Vancomycin-Intermediate Staphylococcus epidermidis: Curio or Omen?
Open Access
- 1 March 1999
- journal article
- Published by Cambridge University Press (CUP) in Infection Control & Hospital Epidemiology
- Vol. 20 (3), 163-165
- https://doi.org/10.1086/501604
Abstract
Vancomycin-Intermediate Staphylococcus epidermidis: Curio or Omen? - Volume 20 Issue 3 - Larry J. StrausbaughKeywords
This publication has 19 references indexed in Scilit:
- The Emergence of Decreased Susceptibility to Vancomycin in Staphylococcus epidermidisInfection Control & Hospital Epidemiology, 1999
- Decreased Susceptibilities to Teicoplanin and Vancomycin among Coagulase-Negative Methicillin-Resistant Clinical Isolates of StaphylococciAntimicrobial Agents and Chemotherapy, 1998
- An electronmicroscope study of glycopeptide antibiotic-resistant strains of Staphylococcus epidermidisJournal of Medical Microbiology, 1993
- In-vitro characteristics of glycopeptide resistant strains of Staphylococcus epidermidis isolated from patients on CAPDJournal of Antimicrobial Chemotherapy, 1993
- Susceptibility of Staphylococcus species and subspecies to teicoplaninAntimicrobial Agents and Chemotherapy, 1991
- Peritonitis due to vancomycin-resistant Staphylococcus epidermidisThe Lancet, 1991
- Emergence of Teicoplanin Resistance During Therapy of Staphylococcus aureus EndocarditisThe Journal of Infectious Diseases, 1990
- Percentages and distributions of teicoplanin- and vancomycin-resistant strains among coagulase-negative staphylococciAntimicrobial Agents and Chemotherapy, 1990
- Antimicrobial resistance in nosocomial isolates of Staphylococcus haemolyticusAntimicrobial Agents and Chemotherapy, 1989
- Emergence of Vancomycin Resistance in Coagulase-Negative StaphylococciNew England Journal of Medicine, 1987